Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherThis Month in JNM

THIS MONTH IN JNM

Journal of Nuclear Medicine January 2005, 46 (1) 8a-9a;
  • Article
  • Info & Metrics
  • PDF
Loading

Lewis looks at the development and current promise of radiolabeled cyclic peptide ligands for αvβ3 as powerful tools for molecular imaging and targeted radiotherapy of tumors undergoing angiogenesis.

Page 2

Figure

Liao and colleagues examine the relative prognostic powers and clinical information provided by 3 assessment techniques in a high-risk population of patients with known or suspected coronary artery disease and discuss possible advantages in combining 2 or more of these approaches.

Page 5

Schinkel and colleagues assess the value and feasibility of pharmacologically induced stress testing in the prediction of mortality and cardiac events in elderly individuals.

Page 12

Brogsitter and colleagues report on the clinical performance of an electrocardiography-gated 3-dimensional 18F-FDG imaging protocol in patients with coronary artery disease and compare results with those from 2-dimensional acquisition.

Page 19

Kluge and colleagues use 18F-FDG SPECT to measure metabolic rates of glucose uptake in myocardium in patients with pulmonary hypertension to identify prognostic parameters for cardiac dysfunction and poor survival.

Page 25

Fukumitsu and colleagues measure and map the distribution of a major subtype A1 adenosine receptor in the human brain using a newly developed radioligand for PET imaging.

Page 32

Kaiboriboon and colleagues apply the technique of composite subtraction ictal SPECT coregistered to MRI to demonstrate typical patterns of hyperperfusion in a group of patients with mesial temporal lobe epilepsy.

Page 38

Xiangsong and colleagues report on a novel approach to evaluating blood perfusion and ammonia metabolism in the pituitary gland and discuss the utility of this method in the diagnosis of hypopituitarism.

Page 44

Salaun and colleagues document the reference range of 18F-FDG uptake in PET imaging of the gastroesophageal junction and gastric antrum in a retrospective study of patients with no history of gastroesophageal disease.

Page 48

Metser and colleagues assessed the role of 18F-FDG PET/CT in the evaluation of solid splenic masses in patients with known malignancy and incidentally found lesions in patients without known malignancy.

Page 52

Figure

Lambert and colleagues detail the pharmacokinetics, organ dosimetry, and toxicity identified in a phase 1 study of intraarterial administration of 188Re-HDD/lipiodol, which shows promise in the palliative treatment of hepatocellular carcinoma.

Page 60

Bartel and colleagues investigate the use of a corn oil emulsion as an inexpensive cholecystagogue and alternative to sincalide in the scintigraphic diagnosis of chronic acalculous cholecystitis.

Page 67

Kaufmann and Camici review the ways in which PET measurement of myocardial blood flow has contributed to advanced understanding of cardiac physiology and pathophysiology and look at the promise of new techniques and innovations.

Page 75

Figure

Emfietzoglou and colleagues compare absorbed dose profiles within avascular prostate carcinoma spheroids for various β-, Auger-, and conversion-emitters delivered by liposomes and a monoclonal antibody and discuss the application of results to antibody-based radiotherapy.

Page 89

Simões and colleagues investigate 124I-FIAU PET imaging of reporter gene expression in an isolated heart perfusion model.

Page 98

Piert and colleagues compare 18F-FAZA with the standard hypoxia tracer 18F-FMISO in detection of tumor tissue hypoxia in murine tumor models.

Page 106

Waldherr and colleagues evaluate in an animal model the utility of 18F-FLT PET to noninvasively measure changes in tumor cell proliferation in vivo after kinase inhibitor therapy.

Page 114

Miao and colleagues examine in a mouse model the efficacy of a promising 188Re-labeled peptide for targeted radionuclide therapy of melanoma.

Page 121

Chattopadhyay and colleagues report on the development and evaluation of a novel PET agent for imaging nicotine α4β2 receptors, which are implicated in the study of Alzheimer’s disease, schizophrenia, substance abuse, lung cancer, and other disorders.

Page 130

Kim and colleagues explore in an animal model the possibility of liver-targeted nuclear imaging with 99mTc-galactosyl–methylated chitosan bound to asialoglycoprotein receptors.

Page 141

Joseph and colleagues assess the role of cytokines in regulating 99mTc-mebrofenin transport and discuss implications for using this process to identify and monitor organ inflammation, including hepatitis, fatty liver disease, allograft rejection, and responses to gene therapy vectors.

Page 146

Govindan and colleagues develop a simple, remote, “1-pot” method for production of a residualizing 131I-labeled monoclonal antibody at levels needed for clinical therapy.

Page 153

Figure

Igarashi and colleagues investigate in a rat model whether changes in myocardial uptake of fatty acid tracer after reperfusion subsequent to transient myocardial ischemia are closely related to alterations in intracellular fatty acid oxidation.

Page 160

De Bondt and colleagues test the performance of 4 algorithms that calculate left and right ventricular ejection fractions from tomographic radionuclide ventriculography and discuss clinical implications of these dynamic cardiac models.

Page 165

Higuchi and colleagues compare autoradiographic uptake of BMIPP and 201Tl in assessing serial changes in fatty acid metabolism associated with acute ischemia and reperfusion in rat hearts.

Page 172

Manrique and colleagues determine the effect of perfusion defect and imaging sequence on the evaluation of myocardial stunning with gated perfusion SPECT, using a dynamic mathematic cardiac torso phantom.

Page 176

Pichler and colleagues report a new application of radiolabeled RGD peptides targeting αvβ3 imaging of delayed-type hypersensitivity reaction in a mouse model of chronic inflammation.

Page 184

ON THE COVER

The putative antagonist 18F-labeled 5-(3′-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine (nifrolidine) has been found to bind to α4β2 receptor–rich regions in rats and monkeys, indicating promise as a PET agent. In these images of rhesus monkey brain, correlation of 18F-nifrolidine PET images with MRI templates indicates significant binding in the thalamic regions and significant uptake by the temporal and frontal cortices. The summed images at bottom show that the anteroventral, anteromedial, and ventrolateral thalami are the regions of highest uptake, consistent with the reported distribution of the α4β2 receptor subtype in rhesus monkeys.

Figure
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 46 (1)
Journal of Nuclear Medicine
Vol. 46, Issue 1
January 1, 2005
  • Table of Contents
  • About the Cover
  • Index by author
  • Supplement "Clinical Practice of Molecular Radiotherapy"
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
THIS MONTH IN JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
THIS MONTH IN JNM
Journal of Nuclear Medicine Jan 2005, 46 (1) 8a-9a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
THIS MONTH IN JNM
Journal of Nuclear Medicine Jan 2005, 46 (1) 8a-9a;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • Radiolabeled RGD Peptides Move Beyond Cancer: PET Imaging of Delayed-Type Hypersensitivity Reaction
  • Prediction of Death and Nonfatal Myocardial Infarction in High-Risk Patients: A Comparison Between the Duke Treadmill Score, Peak Exercise Radionuclide Angiography, and SPECT Perfusion Imaging
  • Prognostic Stratification Using Dobutamine Stress 99mTc-Tetrofosmin Myocardial Perfusion SPECT in Elderly Patients Unable to Perform Exercise Testing
  • 18F-FDG PET for Detecting Myocardial Viability: Validation of 3D Data Acquisition
  • Different Mechanisms for Changes in Glucose Uptake of the Right and Left Ventricular Myocardium in Pulmonary Hypertension
  • Adenosine A1 Receptor Mapping of the Human Brain by PET with 8-Dicyclopropylmethyl-1-11C-Methyl-3-Propylxanthine
  • Quantitative Analysis of Cerebral Blood Flow Patterns in Mesial Temporal Lobe Epilepsy Using Composite SISCOM
  • Dynamic 13N-Ammonia PET: A New Imaging Method to Diagnose Hypopituitarism
  • An Analysis of the 18F-FDG Uptake Pattern in the Stomach
  • Solid Splenic Masses: Evaluation with 18F-FDG PET/CT
  • 188Re-HDD/Lipiodol Therapy for Hepatocellular Carcinoma: A Phase I Clinical Trial
  • Corn Oil Emulsion: A Simple Cholecystagogue for Diagnosis of Chronic Acalculous Cholecystitis
  • Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications
  • Liposome-Mediated Radiotherapeutics Within Avascular Tumor Spheroids: Comparative Dosimetry Study for Various Radionuclides, Liposome Systems, and a Targeting Antibody
  • Myocardial Kinetics of Reporter Probe 124I-FIAU in Isolated Perfused Rat Hearts After In Vivo Adenoviral Transfer of Herpes Simplex Virus Type 1 Thymidine Kinase Reporter Gene
  • Hypoxia-Specific Tumor Imaging with 18F-Fluoroazomycin Arabinoside
  • Monitoring Antiproliferative Responses to Kinase Inhibitor Therapy in Mice with 3′-Deoxy-3′-18F-Fluorothymidine PET
  • Therapeutic Efficacy of a 188Re-Labeled α-Melanocyte–Stimulating Hormone Peptide Analog in Murine and Human Melanoma-Bearing Mouse Models
  • Synthesis and Evaluation of Nicotine α4β2 Receptor Radioligand, 5-(3′-18F-Fluoropropyl)-3-(2-(S)-Pyrrolidinylmethoxy)Pyridine, in Rodents and PET in Nonhuman Primate
  • Hepatocyte-Targeted Nuclear Imaging Using 99mTc-Galactosylated Chitosan: Conjugation, Targeting, and Biodistribution
  • Regulation of Hepatobiliary Transport Activity and Noninvasive Identification of Cytokine-Dependent Liver Inflammation
  • Clinical-Scale Radiolabeling of a Humanized Anticarcinoembryonic Antigen Monoclonal Antibody, hMN-14, with Residualizing 131I for Use in Radioimmunotherapy
  • Evaluation of Fatty Acid Metabolism in Hearts After Ischemia–Reperfusion Injury Using a Dual-Isotope Autoradiographic Approach and Tissue Assay for Metabolites of Tracer
  • Accuracy of 4 Different Algorithms for the Analysis of Tomographic Radionuclide Ventriculography Using a Physical, Dynamic 4-Chamber Cardiac Phantom
  • Time Course of Discordant BMIPP and Thallium Uptake After Ischemia and Reperfusion in a Rat Model
  • Effect of Perfusion Pattern and Imaging Sequence on Gated Perfusion SPECT Evaluation of Myocardial Stunning
  • Imaging of Delayed-Type Hypersensitivity Reaction by PET and 18F-Galacto-RGD
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire